Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: Modulation by nitric oxide synthase inhibition
- 30 September 1996
- journal article
- Published by Elsevier in Metabolism
- Vol. 45 (9) , 1147-1152
- https://doi.org/10.1016/s0026-0495(96)90015-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complicationsDiabetes/Metabolism Research and Reviews, 1994
- Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reactionDiabetes, 1994
- Glycation Products and the Pathogenesis of Diabetic ComplicationsDiabetes Care, 1992
- Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic ratsDiabetologia, 1992
- Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidineDiabetes, 1992
- Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic ratDiabetes, 1991
- Role of oxidative stress in development of complications in diabetesDiabetes, 1991
- Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.Journal of Clinical Investigation, 1991
- End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen.Journal of Clinical Investigation, 1990
- Nerve Blood Flow and Oxygen Delivery In Normal, Diabetic, and Ischemic NeuropathyPublished by Elsevier ,1989